Skip to content

High-intensity Laser Therapy Improves Pain, Health Status and Quality of Life in Women With Fibromyalgia

High-intensity Laser Therapy Improves Pain, Health Status and Quality of Life in Women With Fibromyalgia: A Single Blinded-randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05904990
Enrollment
52
Registered
2023-06-15
Start date
2023-01-29
Completion date
2023-09-01
Last updated
2024-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Brief summary

This study will be conducted to investigate High-intensity laser therapy improves pain, health status and quality of life in women with fibromyalgia

Interventions

DEVICEtraditional exercise therapy only

50-minute program included a 10-minute warm-up phase (treadmill walking at a comfortable speed), 30 minutes of stretching exercises for (glutei, paraspinal muscles, hamstring, pectoralis, scalenus, intercostal muscles, and trapezius), and a 10-minute cool-down involving self-stretching and respiratory exercises

DEVICEHILT alongside traditional exercise therapy

YAG laser device (HIRO 3.0; ASA Laser, Arcugnano, Italy). This equipment delivers pulsed laser light at a wavelength of 1,064 nm, with a very high peak power of 3 kW and energy density ranging from 360 to 1,780 mJ/cm2. It operates with short pulse durations between 120 and 150 μs, at low frequencies of 10 to 40 Hz, and has a duty cycle of about 0.1%.

Sponsors

October 6 University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

High intensity laser

Eligibility

Sex/Gender
FEMALE
Age
25 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1. WPI ≥ 7/19 pain sites and SSS ≥ 5/12 or WPI between \> 3-6/19 and SSS \> 9/12 2. symptoms have been present at a similar level for at least 3 months 3. the patient does not have another disorder that would otherwise sufficiently explain the pain 4. generalized pain, defined as pain in at least four of five regions, is present

Exclusion criteria

* uncontrolled diabetes * known history of cancer

Design outcomes

Primary

MeasureTime frameDescription
Revised Fibromyalgia Impact Questionnaire (FIQR)up to 6 weeksassesses the overall severity of FM and health status based on participant ratings. It encompasses three key domains similar to the FIQ (function, overall impact, and symptoms), with additional inquiries regarding memory, tenderness, balance, and environmental sensitivity
Visual Analog Scale (VAS)up to 6 weeks10 cm, where patients rated their pain on a scale from 0 (no pain) to 10 (extremely severe pain ) over the past 3 days
pressure algometerup to 6 weeksThis tool comprises a circular rubber tip (1 cm2) and a pressure gauge for displaying readings in kilograms. Given the rubber tip's 1 cm² area, measurements were reported in kilograms per square centimeter (kg/cm2). The algometer has a measurement range from 0 to 10 kg, with increments of 0.1 kg. The instrument was pressed against the skin's surface at a right angle, and the force exerted was registered on a manometer.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026